US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 4.850
  • +0.250+5.43%
Close Nov 22 16:00 ET
  • 4.840
  • -0.010-0.21%
Post 19:57 ET
410.62MMarket Cap-1971P/E (TTM)

Verve Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Verve Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 3.173M --
-- 2024/Q4 -- / 4.238M --
-- 2024/Q3 6.865M / 3.256M --
Aug 8, 2024 2024/Q2 6.692M / 2.711M --
-- 2024/Q1 5.695M / 2.250M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.173M--
--2024/Q4-- / 4.238M--
--2024/Q36.865M / 3.256M--
Aug 8, 20242024/Q26.692M / 2.711M--
--2024/Q15.695M / 2.250M--

Unlock Free Earnings Estimates

Verve Therapeutics Earnings Reports

  • Verve Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 5 20:31

  • Verve Therapeutics | 8-K: Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results

    Nov 5 20:16

  • Verve Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 19:34

  • Verve Therapeutics | 8-K: Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results

    Aug 8 19:19

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 6, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data